Phenominer Database Results (16 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
BN systolic blood pressure controlled sodium content drinking water (1 %) (for 15 days) Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. arterial blood pressure trait male 99.0 days 64 continuous mean 134.4 mmHg 8.7 69.6 vascular indwelling catheter method femoral artery 1800 pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) 65342 306
BN plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 20 91.3 mg/dl 1.5 6.71 oral glucose tolerance test 0.0 oral glucose min 68069 836
BN volume of liver occupied by tumorous lesions as percentage of total liver volume N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. liver integrity trait female  days 3 1.61 % 0.46 0.8 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethtlamine injection 56 days 68620 950
BN plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 20 120.5 mg/dl 2.6 11.63 oral glucose tolerance test 0.0 oral glucose 120 min 68081 836
BN plasma glucose level fasting (for 16 hours) then glucose solution Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. blood glucose amount male 210.0 days 20 91.3 mg/dl 1.5 6.71 oral glucose tolerance test 0.0 glucose challenge min 12779 312
BN liver remodeling tumorous lesion number to liver total tumorous lesion number ratio N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy then 5-bromo-2'-deoxyuridine (50 mg/kg) (for 2 hours) Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. liver integrity trait male  days 5 180.0 % 4.0 8.94 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethtlamine injection 56 days 69144 950
BN plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 20 138.7 mg/dl 2.6 11.63 oral glucose tolerance test 0.0 oral glucose 90 min 68078 836
BN ratio of apoptotic bodies to intact tumor cells in nonremodelling liver tumorous lesions N-nitrosodiethylamine (150 mg/kg) then controlled protein content diet (for 15 days) and controlled 2-acetamidofluorene content diet (0.02 %) then partial hepatectomy De Miglio MR, et al., Int J Cancer 2003 May 20;105(1):70-5. liver integrity trait not specified  days 1.55 % 0.09 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 84780 1603
BN abdominal fat pad weight control condition (for 16 hours) Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. abdominal fat pad mass male 210.0 days 5 6.4 g post excision weight measurement 0.0 67221 312
BN body weight control condition Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 body mass male 210.0 days 20 355.3 g 5.8 25.94 body weighing method 0.0 68066 836
BN liver tumorous lesion number N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. liver integrity trait female  days 3 1717.0 null 227.0 393.18 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethtlamine injection 56 days 68618 950
BN plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 20 124.8 mg/dl 2.3 10.29 oral glucose tolerance test 0.0 oral glucose 30 min 68072 836
BN plasma glucose level fasting (for 16 hours) then glucose solution (2 g/kg) Kanemoto N, et al., Mamm Genome 1998 Jun;9(6):419-25 blood glucose amount male 210.0 days 20 129.8 mg/dl 1.7 7.6 oral glucose tolerance test 0.0 oral glucose 60 min 68075 836
BN plasma glucose level fasting (for 16 hours) then glucose solution (for 0.5 hours) Watanabe TK, et al., Genomics 1999 Jun 15;58(3):233-9. blood glucose amount male 210.0 days 20 124.8 mg/dl 2.3 10.29 oral glucose tolerance test 0.0 glucose challenge 30 min 12783 312
BN percentage of study population developing experimental autoimmune encephalomyelitis during a period of time central nervous system myelin (5 mg/ml) and Freund's complete adjuvant (50 %) Roth MP, et al., J Immunol 1999 Feb 15;162(4):1917-22. central nervous system integrity trait not specified 70.0 days-122.0 days 9 0.0 % in vivo visual assessment 0.0 69967 1278
BN ratio of apoptotic bodies to intact tumor cells in remodelling liver tumorous lesions N-nitrosodiethylamine (150 mg/kg) then controlled protein content diet (for 15 days) and controlled 2-acetamidofluorene content diet (0.02 %) then partial hepatectomy De Miglio MR, et al., Int J Cancer 2003 May 20;105(1):70-5. liver integrity trait not specified  days 2.08 % 0.18 ex vivo light microscopy with immunohistochemistry and digital image analysis 0.0 84783 1603